Ligand validation:7GLN

DMS: DIMETHYL SULFOXIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7GLN_DMS_B_401	88%	77%	0.107	0.983	0.45	0.48	-	-	1	0	100%	1
7GLN_DMS_B_402	62%	71%	0.128	0.921	0.68	0.43	-	-	0	0	100%	1
7GLN_DMS_A_404	50%	73%	0.197	0.948	0.73	0.33	-	-	0	0	100%	1
7GLN_DMS_A_403	46%	58%	0.167	0.902	0.53	1.07	-	-	3	0	100%	1
7GLN_DMS_A_402	45%	68%	0.21	0.942	0.58	0.66	-	-	0	0	100%	1
7GLN_DMS_B_403	31%	50%	0.201	0.869	0.65	1.27	-	1	0	0	100%	1
7GLN_DMS_A_401	21%	71%	0.232	0.839	0.56	0.56	-	-	0	0	100%	1
7GLN_DMS_A_405	17%	71%	0.248	0.823	0.7	0.44	-	-	0	0	100%	1
7GLN_DMS_A_408	7%	70%	0.305	0.766	0.68	0.5	-	-	0	0	100%	1
7GES_DMS_A_401	100%	86%	0.037	0.994	0.38	0.33	-	-	0	0	100%	1
5RFZ_DMS_A_401	100%	95%	0.04	0.993	0.26	0.14	-	-	0	0	100%	1
7AXM_DMS_A_503	100%	65%	0.041	0.994	0.62	0.73	-	-	0	0	100%	1
5REG_DMS_A_403	100%	97%	0.042	0.993	0.18	0.14	-	-	0	0	100%	1
5REU_DMS_A_401	100%	97%	0.043	0.994	0.26	0.08	-	-	0	0	100%	1
6TOV_DMS_A_102	100%	88%	0.028	0.998	0.33	0.35	-	-	0	0	100%	1
6TVE_DMS_P_604	100%	90%	0.031	0.997	0.47	0.15	-	-	0	0	100%	1
5RXA_DMS_A_903	100%	88%	0.032	0.994	0.18	0.48	-	-	0	0	100%	1
7QY0_DMS_A_610	100%	76%	0.032	0.997	0.67	0.3	-	-	0	0	100%	1
5RXR_DMS_A_902	100%	89%	0.037	0.995	0.16	0.47	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.